Marie Namey

480 total citations
15 papers, 354 citations indexed

About

Marie Namey is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Marie Namey has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 2 papers in Neurology. Recurrent topics in Marie Namey's work include Multiple Sclerosis Research Studies (12 papers), Polyomavirus and related diseases (6 papers) and Acute Lymphoblastic Leukemia research (2 papers). Marie Namey is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Polyomavirus and related diseases (6 papers) and Acute Lymphoblastic Leukemia research (2 papers). Marie Namey collaborates with scholars based in United States, Canada and United Kingdom. Marie Namey's co-authors include Jill S. Fischer, James E. Aikens, R. A. Rudick, June Halper, L. Morgante, RA Rudick, Rosalind Kalb, Margie O’Leary, J. A. Cohen and Kathleen M. Schwetz and has published in prestigious journals such as Multiple Sclerosis Journal, Journal of Behavioral Medicine and The Neurologist.

In The Last Decade

Marie Namey

15 papers receiving 339 citations

Peers

Marie Namey
Jennifer Smrtka United States
Marie Namey
Citations per year, relative to Marie Namey Marie Namey (= 1×) peers Jennifer Smrtka

Countries citing papers authored by Marie Namey

Since Specialization
Citations

This map shows the geographic impact of Marie Namey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Namey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Namey more than expected).

Fields of papers citing papers by Marie Namey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Namey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Namey. The network helps show where Marie Namey may publish in the future.

Co-authorship network of co-authors of Marie Namey

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Namey. A scholar is included among the top collaborators of Marie Namey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Namey. Marie Namey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Campbell, Trudy L., et al.. (2020). Nursing Management of Gastrointestinal Adverse Events Associated With Delayed-Release Dimethyl Fumarate: A Global Delphi Approach. Journal of Neuroscience Nursing. 52(2). 72–77. 4 indexed citations
2.
Caon, Christina, et al.. (2015). Prevention and Management of Infusion-Associated Reactions in the Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis (CARE-MS) Program. International Journal of MS Care. 17(4). 191–198. 33 indexed citations
3.
Filipi, Mary L., et al.. (2014). Nurses’ Perspective on Approaches to Limit Flu-Like Symptoms During Interferon Therapy for Multiple Sclerosis. International Journal of MS Care. 16(1). 55–60. 15 indexed citations
4.
Gulick, Elsie E., Marie Namey, & June Halper. (2011). Monitoring My Multiple Sclerosis. International Journal of MS Care. 13(3). 137–145. 13 indexed citations
5.
Namey, Marie, et al.. (2010). Best Practices in Multiple Sclerosis. Journal of Infusion Nursing. 33(2). 98–111. 8 indexed citations
6.
Gulick, Elsie E., June Halper, & Marie Namey. (2008). Job Satisfaction of Multiple Sclerosis Certified Nurses. International Journal of MS Care. 10(3). 69–75. 2 indexed citations
7.
Morgante, L., et al.. (2006). Decision Making in Multiple Sclerosis: Theory to Practice. International Journal of MS Care. 8(4). 113–120. 9 indexed citations
8.
Namey, Marie, et al.. (2004). Long-Term Treatment Optimization in Individuals with Multiple Sclerosis Using Disease-Modifying Therapies. Journal of Neuroscience Nursing. 36(1). 10–22. 16 indexed citations
9.
Halper, June, et al.. (2003). Rethinking Cognitive Function in Multiple Sclerosis: A Nursing Perspective. Journal of Neuroscience Nursing. 35(2). 70–81. 15 indexed citations
10.
Holland, Nancy J., June Halper, Rosalind Kalb, et al.. (2001). Adherence to Disease-Modifying Therapy in Multiple Sclerosis: Part I. Rehabilitation Nursing. 26(5). 172–176. 22 indexed citations
11.
Holland, Nancy J., June Halper, Rosalind Kalb, et al.. (2001). Adherence to Disease-Modifying Therapy in Multiple Sclerosis: Part II. Rehabilitation Nursing. 26(6). 221–226. 27 indexed citations
12.
Aikens, James E., Jill S. Fischer, Marie Namey, & R. A. Rudick. (1997). A Replicated Prospective Investigation of Life Stress, Coping, and Depressive Symptoms in Multiple Sclerosis. Journal of Behavioral Medicine. 20(5). 433–445. 100 indexed citations
13.
Weinstock‐Guttman, Bianca, R. Philip Kinkel, J. A. Cohen, et al.. (1997). TREATMENT OF FULMINANT MULTIPLE SCLEROSIS WITH INTRAVENOUS CYCLOPHOSPHAMIDE. The Neurologist. 3(3). 178–185. 36 indexed citations
14.
Rudick, RA, et al.. (1995). Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains. Multiple Sclerosis Journal. 1(3). 150–155. 42 indexed citations
15.
Namey, Marie, et al.. (1988). Multiple sclerosis: a guide for patients and their families. Cleveland Clinic Journal of Medicine. 55(6). 568–569. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026